Overnight Digest: Stocks to look out for on July 31
Overnight Digest: Stocks to look out for on July 31

Overnight Digest: Stocks to look out for on July 31

Shohini Nath Article rating: 5.0

The stocks that are likely to witness significant movement on the bourses on July 31 are HDFC Ltd, Tech Mahindra, Solar Industries, Thomas Cook and Cadila Healthcare.

 

Monte Carlo Q1FY19 profit rises 20 per cent
Monte Carlo Q1FY19 profit rises 20 per cent

Monte Carlo Q1FY19 profit rises 20 per cent

Nidhi Jani Article rating: 5.0

Its EBITDA for the quarter rose by 57.1 per cent YoY to Rs. 13.32 crore, with a corresponding margin expansion of 316 bps. The EBITDA margin for the quarter stood at 16.5 per cent.

S&P BSE hits all-time high, 5 stocks contribute
S&P BSE hits all-time high, 5 stocks contribute

S&P BSE hits all-time high, 5 stocks contribute

Bhagyashree Vivarekar Article rating: 2.5

S&P BSE 200 index opened with a gap-up on Monday, followed by a gap filling but ultimately bounced back to close in green at its peak levels. The index had given a multiple resistance breakout near 4,750 and since then has hit higher high with just one breather in between. 5 BSE 200 stocks hit 52-week high on Monday.

Escorts Q1FY19 profit jumps up by 92.7 per cent
Escorts Q1FY19 profit jumps up by 92.7 per cent

Escorts Q1FY19 profit jumps up by 92.7 per cent

Nidhi Jani Article rating: 5.0

In terms of volume, tractor volume grew by 39.5 per cent at 24,494 units and construction equipment volume grew by 51.8 per cent to 1,345 units.

Reliance Industries posts good Q1 results
Reliance Industries posts good Q1 results

Reliance Industries posts good Q1 results

Nidhi Jani Article rating: 4.6

Jio has continued its strong subscriber growth trend with net addition during the quarter of 28.7 million (as against 26.5 million in the previous quarter). This is the highest net addition in any quarter since the launch of commercial services.

Vanta Bioscience announces foray into clinical research
Vanta Bioscience announces foray into clinical research

Vanta Bioscience announces foray into clinical research

Amir Shaikh Article rating: 5.0

The company stated that clinical research business will hit top-line from the last quarter of the ongoing financial year. The company is expecting to add a revenue of Rs. 250 crores in the fifth year through clinical research services.

Bank of Baroda surges on strong Q1FY19 results
Bank of  Baroda surges on strong Q1FY19 results

Bank of Baroda surges on strong Q1FY19 results

Rohan Takalkar Article rating: 4.0

 

The net interest income for the quarter increased by 28 per cent yoy and 9.5 per cent qoq to Rs. 4,381 crore in Q1FY19 vs Rs. 3,405 crore in the same period the previous year. The interest income for the quarter rose by 10.3 per cent yoy to Rs. 11,639 crore in Q1FY19.

RSS
First28702871287228732875287728782879Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR